SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Zvi Steinberg who wrote (628)4/21/1998 4:45:00 PM
From: yosi s  Read Replies (1) of 1491
 
Regarding pars

My understanding that BOL is marketing alrex and Lotemax and as such
they are not going to confuse people.
Granted that if BOL mention PARS in its releases it will give PARS more visibility, but they need to sell Alrex and Lotemax.

As for the price coming down, Any thought to interneuron calling of NDA for their stoke meds, and analyst being negative on the whole neurosector. In time this will be positive for PARS. But we need to wait for the end of phase 2 study on hu211.

This is a great buying.......
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News